|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 15-05-06 | Alexion Pharmaceuticals : to bolster rare disease offering with $8.4 billion deal | RE |
| 15-04-29 | Mylan NV : Exclusive - Perrigo expected to reject Mylan's latest offer | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 0.00% | - | - | - | - | - | - | - | 0 | ||
| +0.96% | +1.16% | +5.45% | +2.91% | -7.96% | -12.97% | -12.33% | -25.02% | +215.89% | 43.03B | ||
| +4.02% | +7.79% | +9.89% | +68.73% | +100.95% | +294.33% | +536.67% | +370.63% | - | 32.71B | ||
| -1.69% | -2.89% | +5.48% | +8.30% | -20.86% | +13.70% | -17.71% | -27.71% | +174.02% | 30.29B | ||
| +1.41% | -0.96% | -8.55% | -5.58% | -11.72% | -0.53% | +33.41% | -19.22% | +763.77% | 29.4B | ||
| +1.16% | +9.79% | -2.67% | -10.58% | +1.52% | +14.27% | +22.28% | -22.60% | +163.53% | 25.08B | ||
| +2.40% | +8.49% | -7.16% | - | - | - | - | - | - | 13.54B | ||
| +0.03% | +2.10% | +12.58% | +3.79% | -16.76% | +56.75% | +111.91% | +155.39% | - | 13.35B | ||
| -1.09% | -2.31% | +6.92% | +3.09% | +1.57% | +5.07% | +5.00% | -27.08% | +99.94% | 12.97B | ||
| +0.93% | +0.57% | -0.36% | +3.89% | -6.51% | +107.81% | +77.40% | +101.64% | +223.53% | 12.11B | ||
| +1.05% | -2.97% | +26.93% | +50.23% | -18.93% | +1.41% | -36.77% | -31.12% | +125.22% | 11.19B | ||
| -9.24% | -20.10% | -40.20% | -26.43% | -18.62% | +9.13% | +2,614.85% | - | - | 9.33B | ||
| +0.51% | +1.09% | +24.94% | +21.23% | -5.52% | +26.11% | -9.81% | -46.81% | +124.85% | 9.03B | ||
| +9.41% | +7.68% | +19.10% | +4.68% | -11.40% | -26.60% | - | - | - | 8.59B | ||
| +4.02% | +6.69% | +29.72% | +10.46% | -4.49% | +11.18% | -26.68% | -49.09% | +99.47% | 8.45B | ||
| +0.06% | -4.54% | -14.08% | -15.91% | -29.32% | +1,369.78% | +449.03% | +166.35% | +856.18% | 7.85B | ||
| -0.13% | +2.15% | +12.22% | -8.84% | -21.82% | -25.37% | -28.82% | -30.47% | +53.51% | 7.66B | ||
| -0.77% | +4.46% | -22.78% | -10.01% | -10.25% | +497.16% | +1,848.73% | -12.61% | - | 7.43B | ||
| +0.18% | +4.50% | +18.36% | +59.80% | +58.54% | +48.71% | +38.93% | +80.11% | +5.02% | 7.38B | ||
| -0.71% | +15.74% | +4.11% | +8.30% | +10.00% | +82.26% | +209.32% | +75.25% | - | 7.09B | ||
| Average | +0.66% | +1.48% | +4.20% | +9.34% | -0.64% | +137.34% | +342.08% | +41.10% | +242.08% | 14.82B | |
| Weighted average by Cap. | +0.87% | +1.47% | +3.73% | +11.32% | +4.23% | +96.67% | +229.67% | +48.85% | +272.24% |
- Stock Market
- Stocks
- Stock
- Sector Pharmacyclics, Inc.
Select your edition
All financial news and data tailored to specific country editions
















